STRONG POINT UNIT TO MARKET PRODUCT IN EUROPE IRVINE CALIF MARCH 4  STRONG POINT INC SAID ITS PHARMACEUTICAL TECHNOLOGIES INC SUBSIDIARY WILL MARKET IN EUROPE ITS IMMUNOL RD NUTRITIONAL PRODUCT DESIGNED TO PROTECT INDIVIDUALS EXPOSED TO MEDIUM OR MINIMAL RADIATION DOSAGE LEVELS THE COMPANY SAID IT WILL MARKET THE PRODUCT IN EUROPE BECAUSE OF THE RADIATION EXPOSURE FROM THE CHERNOBYL NUCELAR POWER ACCIDENT THE COMPANY ASSERTED THAT THE PRODUCT CAN OFFSET THE DELETERIOUS EFFECTS OF RADIATION WHICH WEAKENS THE IMMUNE SYSTEM   